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Abstract - Cardiovascular pathology appears to have a major impact in cognitive decline, and early identification and 
correction of cardiovascular morbidity could have a major protective impact on cognitive functioning. However, it is 
not clear how the risk factors for vascular disease can also be risk factors for a general cognitive decline. Regarding cho-
lesterol, its implications in cognitive decline are not very well understood, considering that a high level of cholesterol 
has been associated with both an increased and decreased risk of dementia. In the present context, we decided to study 
correlations between cholesterol concentration and the various subdomains of some main psychometric tests, such as 
MMSE (Mini-Mental State Examination) and MoCA (The Montreal Cognitive Assessment), as well as some measure-
ments for systemic arterial stiffness (brachial and aortic augmentation index) and how they correlate with the afore-
mentioned psychometric parameters. Our results provide additional evidence for a correlation between cholesterol 
levels and cognitive subdomains (with special focus on orientation, attention, recent memory and long-term memory). 
Additionally, a significant correlation was found between the brachial and aortic augmentation index and the results of 
both MMSE and MOCA tests. 
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INTRODUCTION
Cognitive  deficits  generally  increase  with  aging. 
Also, the presence of vascular risk factors such as 
hypertension, cholesterol, diabetes mellitus or the 
presence of heart diseases may increase the risk of 
developing Alzheimer’s disease (AD) (McCullagh 
et al., 2001, Schneider et al., 2004, Luchsinger et al., 
2005, Ciobica et al., 2011c). In this way, cardiovas-
cular pathology appears to have a major impact in 
cognitive decline, and an early identification and 
correction of cardiovascular morbidity could have 
a major protective impact on cognitive functioning 
(Ciobica et al., 2009, 2011a, b). However, it is not 
very clear how the risk factors for vascular disease 
can also be risk factors for a general cognitive de-
cline.
We previously studied the possible connections 
between blood pressure and body mass index to the 
cognitive functions in patients with cardiovascular 
risk factors (Joacabine et al., 2011a, b). It is also be-
lieved that hypertension and hypercholesterolemia 
increase the risk of dementia by inducing atheroscle-
rosis and impairing blood flow, but they may also di-
rectly induce the neurodegeneration of Alzheimer’s 
disease  (Kivipelto  et  al.,  2001).  Regarding  choles-
terol, it is generally accepted that high total choles-420 CATALIN JOACABINE ET AL.
terol is a common marker of cardiovascular and cer-
ebrovascular pathology. However, its implications in 
cognitive decline are not very well understood, con-
sidering that a high level of cholesterol has been as-
sociated with both an increased and decreased risk of 
dementia (Notkola et al., 1998, Kivipelto et al., 2002, 
Solomon et al., 2007, Ciobica et al., 2011).
We decided to study the degree of cognitive de-
cline in selected patients with reported cardiovascu-
lar problems. Moreover, in the present paper we will 
extensively present the correlations between choles-
terol concentration and the various subdomains of 
some  of  the  main  psychometric  tests,  like  MMSE 
(Mini-Mental State Examination) and MoCA (The 
Montreal Cognitive Assessment). Additionally, con-
sidering the importance of cholesterol in increasing 
vascular resistance and rigidity, in the present paper 
we will determine some indices for peripheral vas-
cular resistance (brachial and aortic augmentation 
index, which are a measure for the systemic arterial 
stiffness (Fantin et al., 2007)) and how they correlate 
with the aforementioned psychometric parameters.
MATERIALS AND METHODS
This study (n=95 patients) consisted of 80 patients 
(46 females and 34 males; age: 61.2 years±4.7), with 
reported  cardiovascular  problems,  and  15  healthy 
age-matched controls (9 females and 6 males; age: 
59.5  years±5.8).  Patients  were  recruited  from  the 
University Hospital of Psychiatry “Socola”, Iaşi, Ro-
mania.
Exclusion criteria were represented by acute co-
morbidities, chronic unstable diseases as well as pa-
tients with other medical conditions that could lead 
to cognitive deficits apart from cardiovascular and 
metabolic dysfunction.
Healthy  control  subjects  had  major  psychiat-
ric disorders excluded based on history taking and 
psychiatric examination, according to the DSM-IV 
checklist. The demographic data of the controls were 
chosen in order to match the patients with cardio-
vascular problems. 
Cognitive testing was performed in the morning, 
between 10-12 a. m. Blood samples were obtained in 
the morning before breakfast. Blood was allowed to 
clot and was centrifuged immediately (Padurariu et 
al., 2010 a, b). Sera were aliquoted into Eppendorf 
tubes and stored at -80°C until determination of se-
rum total cholesterol concentrations, which was per-
formed in the hospital central laboratory.
The augmentation index is an indirect measure 
of arterial stiffness. It is calculated as augmentation 
pressure divided by pulse pressure ×100 to give a 
percentage. With an increase in stiffness, there is 
a faster propagation of the forward pulse wave as 
well as a more rapid reflected wave (O’Rourke et 
al., 2008). Measurement of the brachial and aor-
tic augmentation index was performed by using a 
TensioMed Arteriograph (Budapest, Hungary). All 
readings  recorded  met  the  manufacturer’s  qual-
ity control standards integrated into the software 
package.
The  study  was  conducted  according  to  provi-
sions of the Helsinki Declaration and all the patients 
signed consent for participation in this study.
Statistical analysis
The  results  for  the  cholesterol  levels  and  brachial 
and aortic augmentation index were analyzed using 
one-way analysis of variance (one-way ANOVA). All 
results are expressed as mean ± SEM. F values for 
which p<0.05 were regarded as statistically signifi-
cant (Hritcu et al., 2011, Hogas et al., 2011, Padurariu 
et al., 2012). In addition, Pearson’s correlation coef-
ficient was used to evaluate the connection between 
the cholesterol levels or the brachial and aortic aug-
mentation index values versus various subdomains 
of  certain  psychometric  tests  such  as  MMSE  and 
MOCA.
RESULTS
Our  initial  analysis  included  cholesterol  levels. 
As  expected,  we  observed  a  significant  increase 
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in patients with reported cardiovascular problems, 
compared to our control group (Fig. 1).
More importantly, when we analyzed the con-
nections between the cholesterol levels and the re-
sults from the MMSE and MOCA tests, we found 
significant  negative  correlations  for  cholesterol  vs. 
MMSE (n=95, r=-0.308, p= 0.002) (Fig. 2) and for 
cholesterol vs. MOCA (n=95, r=-0,366, p<0.0001) 
(Fig. 3).
Additionally, we found significant negative cor-
relations between the values of the cholesterol level 
and some of the subdomains of both MMSE: cho-
lesterol  vs.  orientation  (n=95,  r=-0.195,  p<0.047) 
(Fig. 4A), cholesterol vs. attention (n=95, r=-0.406, 
p< 0.0001) (Fig. 4C), cholesterol vs. recent memory 
(n=95,  r=-0.305,  p=  0.003)  (Fig.  4D)  and  MOCA 
tests: cholesterol vs. long-term memory (n=95, r= 
-0.198, p= 0.048) (Fig. 5F).
However, in the case of some subdomains of the 
MMSE test, we could not find any significant cor-
relations as in the case of cholesterol vs. short-term 
memory (n=95, r=-0.094, p=0.364) (Fig. 4B), choles-
terol vs. language (n=95, r=-0.094 , p= 0.367) (Fig. 
4E) and cholesterol vs. executive functions (n=95, r= 
-0.01 , p=0.925) (Fig. 4F). Also, we did not observe any 
correlations between cholesterol values and the rest 
of the cognitive subdomains of the MOCA test: cho-
lesterol  vs.  visuospatial/executive  functions  (n=95, 
r=-0.039, p= 0.711) (Fig. 5A), cholesterol vs. naming 
(n=95, r=-0.046, p=0.657) (Fig. 5B), cholesterol vs. 
attention (n=95, r=-0.156, p=0.132) (Fig. 5C), cho-
lesterol vs. language (n=95, r=-0.105, p=0.315) (Fig. 
5D), cholesterol vs. abstractization (n=95, r=-0.084, 
p=0.419)  (Fig.  5E)  and  cholesterol  vs.  orientation 
(n=95, r=-0,077, p<0,456) (Fig. 5G).
Regarding  the  values  of  the  augmentation  in-
dex, we demonstrated a significant decrease of both 
the brachial (F(1.93)=11, p=0.042) (Fig. 6), as well 
as aortic augmentation index (F(1.93)=19, p=0.03) 
(Fig. 7) in the patients with reported cardiovascular 
problems, as compared to the control group.
Fig. 1. Cholesterol concentration in cardiovascular patients and 
controls. The values are mean ± S.E.M. (n=80 for cardiovascular 
patients and n=15 per control group). ** p < 0,001.
Fig. 2. Correlations between cholesterol levels and MMSE (n=95, 
r= -0,308, p= 0,002)
Fig. 3. Correlations between cholesterol levels and MOCA test. 
(n=95, r= -0,366, p< 0,0001).422 CATALIN JOACABINE ET AL.
Fig. 4. Correlations between cholesterol levels and the subdomains of MMSE.THE ASSOCIATION BETWEEN CHOLESTEROL LEVELS AND BRACHIAL/AORTIC INDEX 423
Fig. 5. Correlations between cholesterol levels and the subdomains of MOCA test.424 CATALIN JOACABINE ET AL.
Fig. 8. Correlations between brachial/aortic augmentation index and the MMSE/MOCA tests.
Fig. 6. Brachial augmentation index in cardiovascular patients 
and controls. The values are mean ± S.E.M. (n=80 for cardiovas-
cular patients and n=15 per control group). * p = 0,042.
Fig. 7. Aortic augmentation index in cardiovascular patients and 
controls. The values are mean ± S.E.M. (n=80 for cardiovascular 
patients and n=15 per control group). * p = 0,03.THE ASSOCIATION BETWEEN CHOLESTEROL LEVELS AND BRACHIAL/AORTIC INDEX 425
More importantly, when we analyzed the connec-
tions between the cholesterol levels and the results 
from MMSE and MOCA tests, we found significant 
correlations  between  MMSE  vs.  brachial  augmen-
tation  index  (n=95,  r=0.517,  p<0.0001)  (Fig.  8A), 
as well as for MMSE vs. aortic augmentation index 
(n=95, r= 0.591, p<0.0001) (Fig. 8B). Also, significant 
correlations were reported between MOCA vs. bra-
chial augmentation index (n=95, r=0.493, p<0.0001) 
(Fig. 8C), as well as for MOCA vs. aortic augmenta-
tion index (n=95, r=0.589, p< 0.0001) (Fig. 8D).
DISCUSSION
Our results provide additional evidence for a correla-
tion between cholesterol levels and cognitive deficits 
(Notkola et al., 1998, Kivipelto et al., 2002, Solomon et 
al., 2007, Ciobica et al., 2011), expressed in our study 
by the specific scores of the MMSE and MOCA tests. 
Moreover,  we  demonstrated  a  series  of  significant 
correlations between cholesterol values and some of 
the subdomains from the MMSE and MOCA tests. 
Additionally, a significant correlation was found be-
tween some measurements of the systemic arterial 
stiffness  (brachial  and  aortic  augmentation  index) 
and the results of both MMSE and MOCA tests.
As previously mentioned, a high level of cho-
lesterol was associated with both an increased and 
decreased risk of dementia. It seems that this varies 
mainly with the age of the studied patients. In this 
way, a decreased level of serum cholesterol was dem-
onstrated to have a positive correlation with cognitive 
regression in late-life (Solomon et al., 2007), while 
there is also evidence that cholesterol is starting to 
decrease several years before the onset of dementia, 
and this could be used as a marker for the risk of AD 
(Mielke et al., 2005). In addition, other studies iden-
tified cholesterol as a risk factor for AD when this 
was found in middle-aged patients (Notkola et al., 
1998, Kivipelto et al., 2002, Solomon et al., 2007).
Regarding the augmentation index, this is con-
sidered to be a measure of systemic arterial stiffness 
(Fantin et al., 2007, O’Rourke et al., 2008). Previous 
studies have demonstrated an association between the 
augmentation index and risk factors of cardiovascu-
lar disease (Janner et al., 2011). In addition, there are 
many gaps in this area of research, especially regard-
ing the age and gender differences of the observed 
associations (Janner et al., 2011). However, in our 
study we were more interested to find the connec-
tions between the brachial and aortic augmentation 
index and the results of some specific cognitive tests, 
such as MMSE and MOCA. The strong connections 
that were demonstrated between these aspects can be 
also applied at the central level and further studies in 
this area seem warranted. Interestingly enough, the 
brachial  and  aortic  augmentation  index  exhibited 
much stronger connections with the cognitive tests, 
in comparison with cholesterol, which might suggest 
their possible superiority as markers for the cogni-
tive decline.
CONCLUSIONS
The present study provides additional evidence for 
the  existence  of  a  correlation  between  cholesterol 
levels and cognitive deficits (with special focus on 
orientation, attention, recent memory and long-term 
memory).  Moreover,  we  demonstrated  significant 
connections between the measurements of systemic 
arterial stiffness, such as the brachial and aortic aug-
mentation index, and the results of the specific cog-
nitive tests (MMSE and MOCA).
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